Skip to main content

Table 2 Pretransplant characteristics at the time of VAD implantation according to pre-transplant VAD infection

From: Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections

Characteristics VAD infection n = 18 No VAD infection n = 17
Age, years; mean (SD) 52.3 (9.7) 39.1 (20)
Gender, male; n (%) 15 (83.3) 14 (82.4)
BMI, kg/m2; mean (SD) 28.4 (6.1) 22.9 (6)
Median time from VAD implantation to transplantation, days; median (IQR) 293.5 (121–593) 101 (37.5-206)
INTERMACS score; median (IQR) 1.5 (1–4) 2 (1–3)
Creatinine, μmol/l; mean (SD) 105.3 (58.6) 90.9 (35.6)
Type of VAD; n (%)   
 - Heartmate® II
 - Berlin Heart® EXCOR
 - Heartware®
 - Thoratec®
 - Levitronics®
9 (37.1)
6 (34.3)
1 (14.3)
2 (11.4)
0 (0.0)
5 (29.4)
6 (35.3)
4 (23.5)
1 (5.8)
1 (5.8)
Active infection at the time of transplant 10/18 (55.5) -
  1. VAD ventricular-assist device, BMI body mass index, INTERMACS interagency registry for mechanically assisted circulatory support